PREVALENCE AND PREDICTORS OF METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE IN A RETROSPECTIVE COHORT OF PATIENTS WITH ULCERATIVE COLITIS

被引:0
|
作者
Elmoursi, Ahmed
Ali, Mohamed
Metawea, Ibrahim
Alareidi, Alaa
Abomhya, Ahmed
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S30 / S31
页数:2
相关论文
共 50 条
  • [1] PREVALENCE AND PREDICTORS OF METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE IN A RETROSPECTIVE COHORT OF PATIENTS WITH ULCERATIVE COLITIS
    Elmoursi, Ahmed
    Ali, Mohamed
    Metawea, Ibrahim
    Alareidi, Alaa
    Abomhya, Ahmed
    INFLAMMATORY BOWEL DISEASES, 2024, 30
  • [2] Identification and validation of hub genes expressed in ulcerative colitis with metabolic dysfunction-associated steatotic liver disease
    Liu, Yupei
    Li, Jiao
    Tian, Shan
    Lan, Qingzhi
    Sun, Zhiyi
    Liu, Chuan
    Dong, Weiguo
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [3] Metabolic dysfunction-associated steatotic liver disease prevalence and predictors in patients with type 2 diabetes in primary care
    Balkhed, Wile
    Nasr, Patrik
    Cai, Shan
    Simonsson, Christian
    Forsgren, Mikael
    Bergram, Martin
    Leinhard, Olof Dahlqvist
    Dahlstrom, Nils
    Carlhall, Carl-Johan
    Lundberg, Peter
    Radholm, Karin
    Iredahl, Fredrik
    Kechagias, Stergios
    Ekstedt, Mattias
    JOURNAL OF HEPATOLOGY, 2024, 80 : S532 - S532
  • [4] Prevalence and Predictors of Suspected Metabolic Dysfunction-Associated Steatotic Liver Disease in Adolescents in the United States
    Noon, Sheila L.
    Chun, Lauren F.
    Lam, Tin Bo Nicholas
    Thai, Nhat Quang N.
    Dunn, Winston
    Schwimmer, Jeffrey B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025,
  • [5] Predictors of Atherosclerotic Cardiovascular Disease Events in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease
    Kawanaka, Miwa
    Nishino, Ken
    Kawada, Mayuko
    Ishii, Katsunori
    Tanikawa, Tomohiro
    Urata, Noriiyo
    Suehiro, Mitsuhiko
    Haruma, Ken
    Kawamoto, Hirofumi
    INTERNAL MEDICINE, 2024,
  • [6] Prevalence and Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease
    Plaza-Aulestia, Nahia
    Ibarguengoitia-Barrena, Oihane
    Sampedro-Andrada, Blanca
    Juan-Lopez, Cristina San
    Morillo-Montanes, Victoria
    Urionaguena, Irati
    Calvo, Itziar
    Seisdedos, David Montero
    Vega-Alvarez, Lucia
    Llorente, Jose Francisco Garcia
    Revenga, Nuria Vegas
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4669 - 4671
  • [7] Establishing of a risk prediction model for metabolic dysfunction-associated steatotic liver disease: a retrospective cohort study
    Li, Nan
    Liu, Chenbing
    Lu, Zhangfan
    Wu, Wenjian
    Zhang, Feng
    Qiu, Lihong
    Shen, Chao
    Sheng, Di
    Liu, Zhong
    BMC GASTROENTEROLOGY, 2025, 25 (01)
  • [8] Increased Prevalence of Barrett's Esophagus in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
    Qapaja, Thabet
    Alsabbagh, Muaz
    Abdel-Razeq, Rashid
    Abu-Rumaileh, Mohammed
    Ibrahim, Mounir
    Abu-Hammour, Mohamad-Noor
    Thota, Prashanthi N.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S419 - S419
  • [9] Metabolic Dysfunction-Associated Steatotic Liver Disease
    Ali, Sajjadh M. J.
    Lai, Michelle
    ANNALS OF INTERNAL MEDICINE, 2025, 178 (01) : ITC1 - ITC17
  • [10] The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults
    Perumpail, Brandon J.
    Manikat, Richie
    Wijarnpreecha, Karn
    Cholankeril, George
    Ahmed, Aijaz
    Kim, Donghee
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 79 (01): : 110 - 118